PANDA Therapeutics secures €160K to advance multi-target Alzheimer’s therapy
Tech.eu Cate Lawrence
PANDA Therapeutics secured €160,000 from Venture Kick to move a multi-target Alzheimer’s therapy toward clinical development. The funding amount is €160,000 (CHF 150,000). It will be used for company formation and business development, including building advisory and CMC/manufacturing readiness plans, plus IP and regulatory planning for later financing and partnerships.
Why it matters
Biotech startup PANDA Therapeutics has obtained €160,000 (CHF 150,000) from Venture Kick to advance a new treatment for Alzheimer’s disease toward clinical development. By targeting multiple harmful p...
Related stories
Sightera Biosciences closes €3M pre-seed to expand its patient-derived AI drug discovery platform
Tech.eu · 1 month ago ·
4
Apply for Anthropic’s AI for Science rare disease research grants
Anthropic ·
19
Aisel Health raises €1.7M pre-seed to build an operating system for psychiatry
Tech Funding News · 2 weeks ago ·
7